 |
doxorubicin nanoparticles |
|---|---|
| Trade Name | Doxorubicin Transdrug |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2005-03-14 00:00:00 |
| Sponsor | Onxeo SA;49 Boulevard du general Martial Valin, 75015;Paris |
| |
doxorubicin nanoparticles |
|---|---|
| Trade Name | Doxorubicin Transdrug |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2005-03-14 00:00:00 |
| Sponsor | Onxeo SA;49 Boulevard du general Martial Valin, 75015;Paris |